PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Fifth of GPs using AI despite lack of guidance or clear work policies, UK survey suggests

Doctors and medical trainees need to be fully informed about pros and cons of these tools

2024-09-17
(Press-News.org) A fifth of family doctors (GPs) seem to have readily incorporated AI into their clinical practice, despite a lack of any formal guidance or clear work policies on the use of these tools, suggest the findings of an online UK-wide snapshot survey, published in the open access journal BMJ Health & Care Informatics.

Doctors and medical trainees need to be fully informed about the pros and cons of AI, especially because of the inherent risks of inaccuracies (‘hallucinations’), algorithmic biases, and the potential to compromise patient privacy, conclude the researchers.

Following the launch of ChatGPT at the end of 2022, interest in large language model-powered chatbots has soared, and attention has increasingly focused on the clinical potential of these tools, say the researchers.

To gauge current use of chatbots to assist with any aspect of clinical practice in the UK, in February 2024 the researchers distributed an online survey to a randomly chosen sample of GPs registered with the clinician marketing service Doctors.net.uk. The survey had a predetermined sample size of 1000.

The doctors were asked if they had ever used any of the following in any aspect of their clinical practice: ChatGPT; Bing AI; Google’s Bard; or ‘Other’. And they were subsequently asked what they used these tools for.

Some 1006 GPs completed the survey: just over half the responses came from men (531; 53%) and a similar proportion of respondents (544;54%) were aged 46 or older.

One in five (205; 20%) respondents reported using generative AI tools in their clinical practice. Of these, more than 1 in 4 (29%; 47) reported using these tools to generate documentation after patient appointments and a similar proportion (28%; 45) said they used them to suggest a differential diagnosis. One in four (25%; 40) said they used the tools to suggest treatment options.

The researchers acknowledge that the survey respondents may not be representative of all UK GPs, and that those who responded may have been particularly interested in AI—for good or bad—potentially introducing a level of bias into the findings. 

Further research is needed to find out more about how doctors are using generative AI and how best to implement these tools safely and securely into clinical practice, they add.

“These findings signal that GPs may derive value from these tools, particularly with administrative tasks and to support clinical reasoning. However, we caution that these tools have limitations since they can embed subtle errors and biases,” they say.

And they point out: “[These tools] may also risk harm and undermine patient privacy since it is not clear how the internet companies behind generative AI use the information they gather. 

“While these chatbots are increasingly the target of regulatory efforts, it remains unclear how the legislation will intersect in a practical way with these tools in clinical practice.” 

And they conclude: “The medical community will need to find ways to both educate physicians and trainees about the potential benefits of these tools in summarising information but also the risks in terms of hallucinations [perception of non-existent patterns or objects], algorithmic biases, and the potential to compromise patient privacy.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Novel triplet regimen yields promising response in advanced-phase chronic myeloid leukemia

2024-09-17
HOUSTON ― According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) – including both accelerated or myeloid blast phases of the disease – or Philadelphia chromosome-positive acute myeloid leukemia (AML) achieved a bone marrow remission when treated with a novel combination of decitabine, venetoclax and ponatinib. Findings from the Phase II clinical trial, published today in The Lancet Haematology, represent an important step forward for patients ...

‘Scuba-diving’ lizards use bubble to breathe underwater and avoid predators

‘Scuba-diving’ lizards use bubble to breathe underwater and avoid predators
2024-09-17
BINGHAMTON, N.Y. -- Presenting the world’s smallest (and scrappiest) scuba diver: A species of semi-aquatic lizard produces a special bubble over its nostrils to breathe underwater and avoid predators, according to new research from Binghamton University, State University of New York.  Lindsey Swerk, an assistant research professor of biological sciences at Binghamton University, studies water anoles, a type of semi-aquatic lizard found in the tropical forests of southern Costa Rica. She had previously documented the lizards using a bubble underwater. When these lizards feel threatened by a predator, ...

USC launches large-scale nationwide study of type 1 diabetes and brain development

2024-09-17
About half of adults with type 1 diabetes face significant cognitive impairment, including problems with working memory and executive function that affect day-to-day thinking. But less is known about how the condition affects children during a window of time known to be critical for healthy brain development. A new large-scale longitudinal study, led by the Keck School of Medicine of USC, will unite 12 research centers across the United States to explore that important question. Researchers will collaborate to recruit a large, diverse group of children newly diagnosed with diabetes, taking a sweeping look at the environmental, lifestyle, ...

Ancestry-specific genetic variants linked to multiple sclerosis risk, new study shows

2024-09-17
A landmark study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that could reshape treatment approaches for diverse populations affected by the disease.1 The research, presented today at ECTRIMS 2024, is the result of efforts by the Alliance for Research in Hispanic MS (ARHMS) Consortium and is the first large-scale study to identify ancestry-specific genetic effects for MS risk. In a comprehensive analysis of over 7,000 individuals from self-reported Hispanic (n=4,313; 2,201 MS, 2,112 controls) and African American (n=3,085; 1,584 MS, 1,501 controls) backgrounds, researchers discovered ...

Early high-efficacy treatment significantly reduces long-term disability in children with multiple sclerosis, new study finds

2024-09-17
New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term disability in multiple sclerosis (MS) patients.1 The study, which utilised data from the French MS Registry, Italian MS Register, and the global MSBase Registry, analysed the outcomes of 282 patients with paediatric-onset MS who began experiencing symptoms before the age of 18 years. Patients were divided into two groups based on when they initiated monoclonal antibody treatment: either ...

Terasaki Institute CEO Dr. Ali Khademhosseini awarded the AIChE’s 2024 Andreas Acrivos Professional Progress

Terasaki Institute CEO Dr. Ali Khademhosseini awarded the AIChE’s 2024 Andreas Acrivos Professional Progress
2024-09-17
Dr. Ali Khademhosseini, Ph.D., CEO and Director of the Terasaki Institute for Biomedical Innovation (TIBI), is honored with the 2024 Andreas Acrivos Award for Professional Progress in Chemical Engineering by the American Institute of Chemical Engineers (AIChE). This distinguished honor recognizes outstanding progress in the field of chemical engineering. Named after Dr. Andreas Acrivos, Albert Einstein Professor of Science and Engineering, emeritus at the City College of New York, whose pioneering work in fluid ...

Slow-moving landslides a growing, but ignored, threat to mountain communities

Slow-moving landslides a growing, but ignored, threat to mountain communities
2024-09-17
American Geophysical Union  17 September 2024  AGU Release 24-33 For Immediate Release  This press release is available online at: https://news.agu.org/press-release/slow-landslides-growing-threat-mountain-communities/ Slow-moving landslides a growing, but ignored, threat to mountain communities Urban growth, climate change, and flood risk at lower elevations can push people to live on steeper, more dangerous terrain AGU press contact: Rebecca Dzombak, news@agu.org (UTC-4 hours) Potsdam press contact: Stefanie Mikulla, University of Potsdam, presse@uni-potsdam.de (UTC+2 hours) Researcher contact: Joaquin Vicente Ferrer, ...

Study finds thousands of browser extensions compromise user data

Study finds thousands of browser extensions compromise user data
2024-09-17
Browser extensions, the software add-ons that help users customize and enhance their web browsers, are wildly popular. Some of the most-used extensions find shopping deals, fix grammar and typos, manage passwords, or translate web pages. The types of extensions available are nearly endless, and many have become indispensable tools for businesses and everyday users.  While these extensions can make web browsing more accessible, productive, and rewarding, they are not without risk. New research from Georgia Tech reveals that thousands of browser extensions pose significant threats to privacy, and hundreds automatically ...

Building better DNA editors: Retrons raise the bar for gene research

Building better DNA editors: Retrons raise the bar for gene research
2024-09-17
SAN FRANCISCO—Within bacterial cells, specialized immune systems known as retrons fend off viral attacks. But that’s not all they can do. Scientists, including Seth Shipman, PhD, at Gladstone Institutes, have shown that retrons also serve an important purpose in the lab: precise DNA editing. In fact, retrons can be combined with CRISPR—the far more famous bacterial-defense-system-turned-gene-editor—to better edit human cells. Yet, for all their potential to help scientists better understand disease and develop new therapies, only a small number of retrons have been studied. In nature, many thousands of variations exist, some with greater gene-editing powers than ...

Study shows SIM models improve health data

2024-09-17
First-of-its-kind research by Tarang Parekh, assistant professor of epidemiology, reviewed the State Innovation Models (SIM), a payment system introduced by the Centers for Medicare and Medicaid Services in 2013, which provides financial incentives to states to develop innovative payment models to improve healthcare systems. In the study, recently published in the American Journal of Epidemiology, Parekh compared data from 2010 to 2015 from three SIM participating states, Arkansas, Massachusetts and Vermont, to Florida, Nebraska and New Mexico, which do not participate in ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] Fifth of GPs using AI despite lack of guidance or clear work policies, UK survey suggests
Doctors and medical trainees need to be fully informed about pros and cons of these tools